Noninvasive detection and monitoring of
drug levels in blood
The company’s platform will be harnessed to pioneer innovative devices for noninvasive monitoring drug levels without the need for a single drop of patient blood. Future indications could include devices for drug management and testing
Proof of concept study
A first monitoring application was demonstrated in a proof-of-concept clinical study:
- In the clinical study, the initial monitoring application aimed to noninvasively and continuously monitor anesthesia levels in patients’ blood in real-time.
- The study successfully demonstrated the capability of IR-MED’s technology to monitor the blood levels of 40 patients undergoing a short medical procedure, all of whom were receiving intravenous (IV) propofol.
- Remarkably, this monitoring was accomplished without the need to withdraw a single drop of blood.”
The company, with suitable partners, will explore and develop future applications for its technology in this field.
